Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Pierre Loulergue"'
Autor:
Aurélie Bocquier, Sébastien Cortaredona, Lisa Fressard, Pierre Loulergue, Jocelyn Raude, Ariane Sultan, Florence Galtier, Pierre Verger
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Annual seasonal influenza vaccination (SIV) is recommended for people with diabetes, but their SIV rates remain far below public health targets. We aimed to identify temporal trajectories of SIV uptake over a 10-year period among
Externí odkaz:
https://doaj.org/article/59be422e9a414979904da3ff0d747588
Autor:
Odile Launay, David J.M. Lewis, Alessandra Anemona, Pierre Loulergue, Jo Leahy, Antonella Silvia Sciré, Anaïs Maugard, Elisa Marchetti, Stefano Zancan, Zhiming Huo, Simona Rondini, Rachid Marhaba, Oretta Finco, Laura B. Martin, Jochen Auerbach, Daniel Cohen, Allan Saul, Christiane Gerke, Audino Podda
Publikováno v:
EBioMedicine, Vol 22, Iss C, Pp 164-172 (2017)
Background: Approximately 164,000 deaths yearly are due to shigellosis, primarily in developing countries. Thus, a safe and affordable Shigella vaccine is an important public health priority. The GSK Vaccines Institute for Global Health (GVGH) develo
Externí odkaz:
https://doaj.org/article/e7f3d56f66554a5294442f6b34bd8f3a
Autor:
Odile Launay, Augustin G. W. Ndiaye, Valentino Conti, Pierre Loulergue, Antonella Silvia Sciré, Anais Maugard Landre, Pietro Ferruzzi, Naouel Nedjaai, Lena Dorothee Schütte, Joachim Auerbach, Elisa Marchetti, Allan Saul, Laura B. Martin, Audino Podda
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The investigational Shigella sonnei vaccine (1790GAHB) based on GMMA (generalized modules for membrane antigens) is immunogenic, with an acceptable safety profile in adults. However, pre-vaccination anti-S. sonnei lipopolysaccharide (LPS) antibody le
Externí odkaz:
https://doaj.org/article/e5d37e82bdc2432a9258059a3aca453d
Autor:
Vincent Muturi-Kioi, David Lewis, Odile Launay, Geert Leroux-Roels, Alessandra Anemona, Pierre Loulergue, Caroline L Bodinham, Annelies Aerssens, Nicola Groth, Allan Saul, Audino Podda
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0157385 (2016)
In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported. It is therefore important to evaluate how these trials should be planned not to
Externí odkaz:
https://doaj.org/article/e59188bcc309459f81533ee156dfee72
Autor:
Pierre Loulergue, Frédéric Bastides, Véronique Baudouin, Jacques Chandenier, Patricia Mariani-Kurkdjian, Bertrand Dupont, Jean-Paul Viard, Françoise Dromer, Olivier Lortholary
Publikováno v:
Emerging Infectious Diseases, Vol 13, Iss 11, Pp 1647-1652 (2007)
African histoplasmosis caused by Histoplasma capsulatum var. duboisii is an invasive fungal infection endemic in central and west Africa. Most of its ecology and pathogenesis remain unknown. H. capsulatum var. capsulatum is an AIDS-defining opportuni
Externí odkaz:
https://doaj.org/article/3eb9d2fc53f94b7e973f1a4bdc803c47
Autor:
Pierre Loulergue, Olivier Mir
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 18, Iss 4, Pp 464-465 (2014)
Externí odkaz:
https://doaj.org/article/c53d35b91fb64b3e98f3584700ad2c09
Autor:
Pierre Loulergue, Jean-Paul Guthmann, Laure Fonteneau, Jean-Baptiste Armengaud, Daniel Levy-Brühl, Odile Launay
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 9, Pp 1766-1767 (2011)
Externí odkaz:
https://doaj.org/article/094600aadc2940eb9b202933d0ade397
Publikováno v:
Emerging Infectious Diseases, Vol 13, Iss 9, Pp 1427-1427 (2007)
Externí odkaz:
https://doaj.org/article/5a946b171880458ea12a0a6c1e843234
Autor:
Jocelyn Raude, Pierre Verger, Sébastien Cortaredona, Pierre Loulergue, Ariane Sultan, Florence Galtier, Lisa Fressard, Aurélie Bocquier
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Public Health
BMC Public Health, BioMed Central, 2019, 19 (1), pp.918. ⟨10.1186/s12889-019-7209-z⟩
BMC Public Health, 2019, 19 (1), pp.918. ⟨10.1186/s12889-019-7209-z⟩
BMC Public Health
BMC Public Health, BioMed Central, 2019, 19 (1), pp.918. ⟨10.1186/s12889-019-7209-z⟩
BMC Public Health, 2019, 19 (1), pp.918. ⟨10.1186/s12889-019-7209-z⟩
Background Annual seasonal influenza vaccination (SIV) is recommended for people with diabetes, but their SIV rates remain far below public health targets. We aimed to identify temporal trajectories of SIV uptake over a 10-year period among French pe
Autor:
Andrew J Pollard, Odile Launay, Jean-Daniel Lelievre, Christine Lacabaratz, Sophie Grande, Neil Goldstein, Cynthia Robinson, Auguste Gaddah, Viki Bockstal, Aurelie Wiedemann, Maarten Leyssen, Kerstin Luhn, Laura Richert, Christine Bétard, Malick M Gibani, Elizabeth A Clutterbuck, Matthew D Snape, Yves Levy, Macaya Douoguih, Rodolphe Thiebaut, Christopher McShane, Benoit Callendret, Stephanie Dincq, Camille Ferrault, Siew Pin Chai, Maire Paule Gyselen, Marleen van Looveren, Sylvia van Ballert, Tinne de Cnodder, Len Roza, Chiara Forcheh, Kate Stevens, Carmela Mastrandrea, Sanne de Ridder, Rachana Gundluru, Nathalie Swales, Vanessa Errijegers, Wouter Willems, Veronika Roorda, Nicola Orzabal, Magdalena Assenberg, Karine Vialatte, Frédéric Remblier, Elodie Porcar, Anton Ottavi, Eugénie Destandau, Christine Schwimmer, Laetitia Moinot, Cédrick Wallet, Florence Allais, Hélène Savel, Naouel Nedjaai, Anaïs Maugard, Nehza Lenzi, Pierre Loulergue, Mathilde Bahuaud, Fabrice Lainé, Bruno Laviolle, Nolwenn Boissel, Elise Thébault, David Vallée, Jean-François Nicolas, Sophie Gilbert, Karima Dahel, Karen Sagorny, Frédéric Lucht, Stéphane Paul, Alice Haccourt Chanavat, Florent Charra, Catherine Mutter, Monique Lambour, Caroline Muller, Anne Hutt-Clauss, Olivia Aranda, Louis Bernard, Valérie Gissot, Marie-Charlotte Hallouin-Bernard, Alain Goudeau, Steve Suzzoni, Eva Auostin, Lysiane Brick, Jose-Luis Lopez-Zaragoza, Giovanna Melic, Murial Carvalho, Chrystel Chesnel, Hakim Hocini, Aurélie Wiedemann, Laurent Hanot, Véronique Rieux, Adeep Puri, Temitope Adeloye, Malcolm Boyce, Jeremy Dennison, Inge Loewenstein, Omar Sahgal, Frans van den Berg, Wendy Calvert, Mary Faldon, Bruce McClain, Marie-Lousie Newell, Geert Molenberghs
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, ⟨10.1016/S1473-3099(20)30476-X⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, ⟨10.1016/S1473-3099(20)30476-X⟩
Summary Background To address the unmet medical need for an effective prophylactic vaccine against Ebola virus we assessed the safety and immunogenicity of three different two-dose heterologous vaccination regimens with a replication-deficient adenov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43c24659b62a3ec06bc9708186876d5
http://hdl.handle.net/20.500.12278/26684
http://hdl.handle.net/20.500.12278/26684